683 Capital Management, LLC Chimerix Inc Transaction History

683 Capital Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$4.76 - $11.25 $1.57 Million - $3.71 Million	-330,061 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$2.05 - $4.32 $61,625 - $129,863	30,061 Added 10.02%	330,061 $1.43 Million
Q4 2018 Feb 14, 2019	BUY	$2.24 - $3.9 $672,000 - $1.17 Million	300,000 New	300,000 $771,000

37M

52.7K

130K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $78.9M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of 683 Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on 683 Capital Management, LLC with notifications on news.